Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR) has been identified by methylome analysis in 2016 as a distinct molecular CNS tumor entity, which is characterized by an in-frame internal tandem duplication in exon 15 of the BCOR gene [14]. The gene discussed is BCOR; the disease is central nervous system neoplasm.